These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 15771568)

  • 21. Lymphoid stroma in the initiation and control of immune responses.
    Mueller SN; Ahmed R
    Immunol Rev; 2008 Aug; 224():284-94. PubMed ID: 18759934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network.
    Rosen H; Goetzl EJ
    Nat Rev Immunol; 2005 Jul; 5(7):560-70. PubMed ID: 15999095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingosine 1-phosphate dependence in the regulation of lymphocyte trafficking to the gut epithelium.
    Kunisawa J; Kurashima Y; Higuchi M; Gohda M; Ishikawa I; Ogahara I; Kim N; Shimizu M; Kiyono H
    J Exp Med; 2007 Oct; 204(10):2335-48. PubMed ID: 17875673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors.
    Gräler MH; Goetzl EJ
    FASEB J; 2004 Mar; 18(3):551-3. PubMed ID: 14715694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function.
    Brinkmann V; Cyster JG; Hla T
    Am J Transplant; 2004 Jul; 4(7):1019-25. PubMed ID: 15196057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood, sphingosine-1-phosphate and lymphocyte migration dynamics in the spleen.
    Arnon TI; Cyster JG
    Curr Top Microbiol Immunol; 2014; 378():107-28. PubMed ID: 24728595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P; Tölle M; Lucke S; von Wnuck Lipinski K; Heusch G; Schuchardt M; van der Giet M; Levkau B
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):607-13. PubMed ID: 17158351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy.
    Taha TA; Argraves KM; Obeid LM
    Biochim Biophys Acta; 2004 Jun; 1682(1-3):48-55. PubMed ID: 15158755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
    Chiba K; Adachi K
    Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunomodulator FTY720 is phosphorylated and released from platelets.
    Anada Y; Igarashi Y; Kihara A
    Eur J Pharmacol; 2007 Jul; 568(1-3):106-11. PubMed ID: 17553484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration.
    Massberg S; von Andrian UH
    N Engl J Med; 2006 Sep; 355(11):1088-91. PubMed ID: 16971715
    [No Abstract]   [Full Text] [Related]  

  • 32. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production.
    Kunisawa J; Kurashima Y; Gohda M; Higuchi M; Ishikawa I; Miura F; Ogahara I; Kiyono H
    Blood; 2007 May; 109(9):3749-56. PubMed ID: 17234743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of sphingosine 1-phosphate modulation on immune outcomes.
    Pinschewer DD; Brinkmann V; Merkler D
    Neurology; 2011 Feb; 76(8 Suppl 3):S15-9. PubMed ID: 21339486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. G-protein-coupled receptors in control of natural killer cell migration.
    Walzer T; Vivier E
    Trends Immunol; 2011 Oct; 32(10):486-92. PubMed ID: 21664184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
    Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
    J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses.
    Wei SH; Rosen H; Matheu MP; Sanna MG; Wang SK; Jo E; Wong CH; Parker I; Cahalan MD
    Nat Immunol; 2005 Dec; 6(12):1228-35. PubMed ID: 16273098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Redistribution of sphingosine 1-phosphate by sphingosine kinase 2 contributes to lymphopenia.
    Sensken SC; Bode C; Nagarajan M; Peest U; Pabst O; Gräler MH
    J Immunol; 2010 Apr; 184(8):4133-42. PubMed ID: 20220090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720 modulates human oligodendrocyte progenitor process extension and survival.
    Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP
    Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokines and lymphocytes: the role of chemokines and their receptors in the immune system.
    Hasegawa H; Fujita S
    Cell Mol Biol (Noisy-le-grand); 2001 Jun; 47(4):599-607. PubMed ID: 11502068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunology. Dietary factors and immunological consequences.
    Hla T
    Science; 2005 Sep; 309(5741):1682-3. PubMed ID: 16150998
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.